Ordinance
on Clinical Trials
with the exception of
Clinical Trials of Medical Devices1
(Clinical Trials Ordinance, ClinO)

of 20 September 2013 (Status as of 26 May 2022)

1 Amended by Annex 2 No 2 of the O of 1 July 2020 on Clinical Trials with Medical Devices, in force since 26 May 2021 (AS 2020 3033).


Open article in different language:  DE  |  FR  |  IT
Art. 16 Death of the person

1 If a per­son who was in­cluded in a clin­ic­al tri­al in an emer­gency situ­ation dies be­fore it has been pos­sible to ob­tain con­sent or re­fus­al in ac­cord­ance with Art­icle 15, the bio­lo­gic­al ma­ter­i­al and the health-re­lated per­son­al data col­lec­ted may only be used if this per­son has con­sen­ted, in an ad­vance dir­ect­ive or oth­er­wise, to the use of such ma­ter­i­al and health-re­lated data for re­search pur­poses.

2 In the ab­sence of a state­ment of wishes as spe­cified in para­graph 1, use is per­miss­ible if con­sent is giv­en by the next of kin or a des­ig­nated trus­ted per­son. Con­sent is gov­erned by Art­icle 8 of the Trans­plant­a­tion Act.

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden